Dr. Sumair M. Akhtar, MD

Dr. Akhtar practices at St. Luke's Hospital - Carbon Campus in Lehighton, Pennsylvania, part of St. Luke's University Health Network.

Dr. Akhtar's NPI, 1023305802, was assigned on June 30, 2011. Dr. Akhtar holds New York license 277562.

Dr. Akhtar's primary practice is St. Luke's Hospital - Carbon Campus, at 500 St Luke's Drive, Lehighton, PA 18235 in Carbon County. The practice phone is (610) 377-7001.

Dr. Akhtar's primary practice is St. Luke's Hospital - Carbon Campus in Lehighton, Pennsylvania, part of St. Luke's University Health Network. Dr. Akhtar is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Akhtar to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akhtar practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Akhtar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Akhtar is board certified in internal medicine by the American Board of Internal Medicine. Dr. Akhtar is licensed in New York.

CMS data shows 957 Medicare services from Dr. Akhtar across 4 procedure codes in 2024, for 391 Medicare patients. Medicare paid $76,511 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 391 Medicare patients who saw Dr. Akhtar in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akhtar's median patient age at 76, with 53% women.

In 2024, Dr. Akhtar wrote 352 Medicare Part D claims for 203 patients. 90% of them were for generic drugs. CMS names the drug for 134 of them, across 7 drugs with 11 or more claims each, at $7,522 in total drug cost. In 2023, CMS named 152 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Akhtar for performance year 2024, reported through an alternative payment model (APM). Dr. Akhtar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Akhtar from 4 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $99.